Nestle logo

Nestle

Last updated January 31, 2026
125
Innovation Areas
3,230
Inventors
16
Collaborations

Ex vivo cellular potentiation agents: NestleRecent Research Landscape

Stem cell exhaustion and post-therapy relapse increase mortality risks. Precise titration of urolithin metabolites restores cellular regenerative capacity to prevent recurrence.

What technical problems is Nestle addressing in Ex vivo cellular potentiation agents?

Exercise induced muscle fatigue

(25)evidences

Loss of muscle mass and functional quality. Preventing atrophy or sarcopenia maintains metabolic health and physical mobility.

Skeletal muscle mass loss

(8)evidences

Systemic metabolic dysfunction leads to involuntary loss of skeletal muscle mass and strength. Addressing this prevents physical frailty and metabolic collapse in chronic disease states.